Revised International Staging System Applied to Real World Multiple Myeloma Patients

We have confirmed the role of RISS in unselected nonclinical trial patients and suggest that increased serum lactate dehydrogenase and high-risk cytogenetics are very robust prognosticators when combined with the ISS.